What the Evidence Shows on Compounded Bioidentical HRT The Menopause Society (formerly NAMS) published a 2020 position statement noting: "Compounded bioidentical hormone therapy (cBHT) is not recommended over FDA-approved bioidentical hormone therapy due to concerns about safety, quality, and the lack of clinical trial data." [11] That position reflects the absence of randomized controlled trials powered to show efficacy or long-term safety for compounded formulations specifically, not for the hormones themselves
In the interest of providing a balanced comparison, there are scenarios where Mochi Health may be the right choice: Brand-name preference: If you specifically want access to FDA-approved, brand-name GLP-1 medications (Wegovy, Ozempic, Mounjaro) and are willing to pay the premium, Mochi Health offers both compounded and brand-name options
Recomendara los servicios y productos de Nurx a cualquiera que los necesite
GLP-1 Weight Loss Drugs and Gastrointestinal Injuries: West Virginia Patient Rights The pursuit of better health often involves difficult choices and new medical treatments
Around half of this increase may be attributable to obesity fueled by the widespread availability of ultra-processed and relatively cheap food options
The same principles apply to tirzepatide and retatrutide, though specific guidelines for retatrutide will not exist until it reaches the market